From designing molecules to making medicines: AI drug discovery enters its next phase
AI is moving from lab novelty to clinical reality. The next test is whether faster molecule…
Latest
- Tencent opens WorkBuddy to more than 100 companies
- From designing molecules to making medicines: AI drug discovery enters its next phase
- Moonshot AI files for Hong Kong IPO as Chinese startups challenge U.S. frontier model leaders
- Eoptolink joins China’s optical module giants in Hong Kong IPO push
- Huawei revenue hits record high as first-half profit falls 36.8% amid surging R&D costs
